EP1599453B1 - 3-Methyl-2- (3- (2-Phenyl-Oxazol-4-Ylmethoxy)-Cyclohexanecarbonyl-Amino Butyric Acid Derivatives and Related Compounds as Ppar Modulators for the Treatment of Type 2 Diabetes and Atherosclerosis